Patents by Inventor Chunfeng SHU

Chunfeng SHU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF
    Publication number: 20210380593
    Abstract: Disclosed are a pyrazolo-heteroaryl derivative, a preparation method and medical use thereof. In particular, this invention relates to a new pyrazolo-heteroaryl derivative as shown in the general formula (I), a preparation method thereof and a pharmaceutical composition containing the derivative and the use thereof as a therapeutic agent, in particular as a TLR7 agonist, wherein each substituent in the general formula (I) is defined in the description.
    Type: Application
    Filed: August 17, 2021
    Publication date: December 9, 2021
    Inventors: Guobao ZHANG, Chunfeng SHU, Qiyue HU, Feng HE, Weikang TAO
  • Pyrazolo-heteroaryl derivative, preparation method and medical use thereof
    Patent number: 11117898
    Abstract: Disclosed are a pyrazolo-heteroaryl derivative, a preparation method and medical use thereof. In particular, this invention relates to a new pyrazolo-heteroaryl derivative as shown in the general formula (I), a preparation method thereof and a pharmaceutical composition containing the derivative and the use thereof as a therapeutic agent, in particular as a TLR7 agonist, wherein each substituent in the general formula (I) is defined in the description.
    Type: Grant
    Filed: November 27, 2017
    Date of Patent: September 14, 2021
    Assignees: Jiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.
    Inventors: Guobao Zhang, Chunfeng Shu, Qiyue Hu, Feng He, Weikang Tao
  • PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF
    Publication number: 20210115046
    Abstract: Disclosed are a pyrazolo-heteroaryl derivative, a preparation method and medical use thereof. In particular, this invention relates to a new pyrazolo-heteroaryl derivative as shown in the general formula (I), a preparation method thereof and a pharmaceutical composition containing the derivative and the use thereof as a therapeutic agent, in particular as a TLR7 agonist, wherein each substituent in the general formula (I) is defined in the description.
    Type: Application
    Filed: November 27, 2017
    Publication date: April 22, 2021
    Inventors: Guobao ZHANG, Chunfeng SHU, Qiyue HU, Feng HE, Weikang TAO